GL1X · GenesisL1 explorer

Research workbench

Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3- KINASE/MTOR inhibitors for the treatment of cancer

Analyse Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3L17
Type
protein
Length
841 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P48736

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein841—P48736

Compared structures

  • 3L17 · Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.